Видео ютуба по тегу Efruxifermin

Доктор Арун Саньял, Новые препараты для лечения MASLD: тирзепатид, ретатрутид, эфруксифермин и ре...
Доктор Арун Саньял, Новые препараты для лечения MASLD: тирзепатид, ретатрутид, эфруксифермин и ре...
Д-р Нага Чаласани, Клинические исследования MASH цирроза печени - эфруксифермин и белапектин, день 2
Д-р Нага Чаласани, Клинические исследования MASH цирроза печени - эфруксифермин и белапектин, день 2
Akero Therapeutics
Akero Therapeutics
S3-E54.2 - Presentation on Efruxifermin in NASH with Fibrosis
S3-E54.2 - Presentation on Efruxifermin in NASH with Fibrosis
S4-E34.6 - From the Vault: Presentation on Efruxifermin in NASH with Fibrosis
S4-E34.6 - From the Vault: Presentation on Efruxifermin in NASH with Fibrosis
S5 - E20.4 - Drug Development Highlights From EASL Congress 2024: Are FGF-21s Induction Therapy or a
S5 - E20.4 - Drug Development Highlights From EASL Congress 2024: Are FGF-21s Induction Therapy or a
S6.5 - Drug Development Week: FGF-21s, Cirrhosis, Resmiterom, Gene therapies
S6.5 - Drug Development Week: FGF-21s, Cirrhosis, Resmiterom, Gene therapies
💊 NASH Treatment: Review Of Current And Future Therapies For Non-Alcoholic Steatohepatitis
💊 NASH Treatment: Review Of Current And Future Therapies For Non-Alcoholic Steatohepatitis
S2-E48.1 - Closing Thoughts On Summer: Mazen Noureddin's Two Big Things
S2-E48.1 - Closing Thoughts On Summer: Mazen Noureddin's Two Big Things
Cirrhosis Reversal: Emerging Treatments For Liver Health - Liver Health Hub
Cirrhosis Reversal: Emerging Treatments For Liver Health - Liver Health Hub
S3-E48.2 - Phase 2B 'Wow!' Results from Akero’s HARMONY Trial
S3-E48.2 - Phase 2B 'Wow!' Results from Akero’s HARMONY Trial
2:22MITOLYN REVIEWS 2025 - The Truth About Mitochondrial Fat Burn - My Honest Personal
2:22MITOLYN REVIEWS 2025 - The Truth About Mitochondrial Fat Burn - My Honest Personal
Is Liver Cirrhosis Reversible? - Fibrosis vs. Cirrhosis – Dr.Berg
Is Liver Cirrhosis Reversible? - Fibrosis vs. Cirrhosis – Dr.Berg
Новости слияний и поглощений: акции Akero Therapeutics взлетели на 19% после приобретения Novo No...
Новости слияний и поглощений: акции Akero Therapeutics взлетели на 19% после приобретения Novo No...
Pharma and Biotech Daily: Novo's Acquisition, FDA Breakthroughs, and Industry Updates
Pharma and Biotech Daily: Novo's Acquisition, FDA Breakthroughs, and Industry Updates
From Drop to Double: Akero's Surging Stock
From Drop to Double: Akero's Surging Stock
S5 - E20.6 - From the Vault: FGF-21s and
S5 - E20.6 - From the Vault: FGF-21s and "Twin-cretins" At EASL Congress 2023
Liver Healing and Regeneration Plus EXTREMELY POWERFUL!!!(Energetically Programmed)
Liver Healing and Regeneration Plus EXTREMELY POWERFUL!!!(Energetically Programmed)
S6 - E4.3 - Expert: Mazen Noureddin Reviews the Exciting MASLD Drug Development Environment
S6 - E4.3 - Expert: Mazen Noureddin Reviews the Exciting MASLD Drug Development Environment
How Do Emerging Therapies Target Liver Fibrosis Pathways? - Liver Health Hub
How Do Emerging Therapies Target Liver Fibrosis Pathways? - Liver Health Hub
S2-E42.1 - FGF drugs in Development - A Promising Class of Agents
S2-E42.1 - FGF drugs in Development - A Promising Class of Agents